TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20872082

Group type: EXPERIMENTAL
Intervention: Adverse Drug Events (ADEs)
Number of subjects: 3459

Group type: EXPERIMENTAL
Intervention: Medication Errors
Number of subjects: 3459

Group type: EXPERIMENTAL
Intervention: Fatal ADEs
Number of subjects: 3459

Group type: EXPERIMENTAL
Intervention: Life-threatening ADEs
Number of subjects: 3459

Group type: EXPERIMENTAL
Intervention: Serious ADEs
Number of subjects: 3459

Group type: EXPERIMENTAL
Intervention: Rate per admission
Number of subjects: 3459
Study: 19576324

Group type: EXPERIMENTAL
Intervention: ERN/LRPT (1 g for 4 weeks advanced to 2 g for 12 weeks)
Number of subjects: 1455

Group type: EXPERIMENTAL
Intervention: ERN/LRPT
Number of subjects: 1455

Group type: COMPARATOR
Intervention: N-ER (0.5 g for 4 weeks titrated in 0.5-g increments every 4 weeks to 2 g for the final 4 weeks)
Number of subjects: 1455

Group type: COMPARATOR
Intervention: N-ER
Number of subjects: 1455
Study: 17054812

Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.42 with balanced crystalloid solution (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional HES 130/0.42 plus unbalanced crystalloid (saline solution) (Group B)
Number of subjects: 30
Study: 15129747

Group type: EXPERIMENTAL
Intervention: One-dimensional stimulus-response mapping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-dimensional stimulus-response mapping
Number of subjects: 0
Study: 11838060

Group type: EXPERIMENTAL
Intervention: Implantation group (20 patients) - implanted with compound artificial bone of HA‐Bone cement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Implantation group
Number of subjects: 40
Study: 9565283

Group type: EXPERIMENTAL
Intervention: Magnetized water oral irrigator
Number of subjects: 29
Study: 7798544

Group type: EXPERIMENTAL
Intervention: Placebo-controlled oral food challenges with cow's milk, hen's egg, cow's milk and hen's egg, or placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eosinophil cationic protein measurement
Number of subjects: 25
Study: 3292997

Group type: EXPERIMENTAL
Intervention: Rimantadine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 30424796

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) guidance
Number of subjects: 1546

Group type: COMPARATOR
Intervention: Standard of care (without PCT guidance)
Number of subjects: 1546
Study: 27052516

Group type: EXPERIMENTAL
Intervention: Padua prediction score (PPS)
Number of subjects: 628

Group type: COMPARATOR
Intervention: Clinical judgment
Number of subjects: 628
Study: 24723220

Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Unipolar depression
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Bipolar disorder
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Bipolar depression
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Bipolar mania
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Overall rate of TSH levels above or below normal range
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Age correlation with TSH levels
Number of subjects: 1685
Study: 24376546

Group type: EXPERIMENTAL
Intervention: Vesico Amniotic Shunt (VAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 0
Study: 20842069

Group type: EXPERIMENTAL
Intervention: Clindamycin for 20 days
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: First-generation cephalosporin for 30 days
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Both treatment groups (Clindamycin and First-generation cephalosporin)
Number of subjects: 131
Study: 18469566

Group type: EXPERIMENTAL
Intervention: Prolotherapy (injections of a solution made from 1 part 5% sodium morrhuate, 1.5 parts 50% dextrose, 0.5 parts 4% lidocaine, 0.5 parts 0.5% sensorcaine and 3.5 parts normal saline)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prolotherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (0.9% saline injections)
Number of subjects: 24
Study: 15842136

Group type: EXPERIMENTAL
Intervention: Weichangshu (WCS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Mosapride Citrate tablet
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups (WCS and Mosapride)
Number of subjects: 96
Study: 12589712

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Radiotherapy with concomitant chemotherapy
Number of subjects: 87
Study: 10496460

Group type: EXPERIMENTAL
Intervention: Acute chocolate ingestion
Number of subjects: 0
Study: 7481231

Group type: EXPERIMENTAL
Intervention: Conservative breast surgery with adjuvant radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant radiotherapy
Number of subjects: 0
Study: 1683249

Group type: EXPERIMENTAL
Intervention: Abanoquil (0.4 micrograms kg‐1 i.v.)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Abanoquil (0.5 micrograms kg‐1 i.v.)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 6257815

Group type: EXPERIMENTAL
Intervention: Trimethoprim-polymyxin B (TP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Trimethoprim-sulfacetamide-polymyxin B (TSP)
Number of subjects: 68
Study: 31765731

Group type: EXPERIMENTAL
Intervention: NFB + tDCS (10 min of tDCS before each NFB session, 2 days per week, 10 sessions of 30 min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: NFB (2 days per week, 10 sessions of 30 min)
Number of subjects: 16
Study: 31294924

Group type: EXPERIMENTAL
Intervention: methylphenidate + tipepidine
Number of subjects: 53

Group type: COMPARATOR
Intervention: methylphenidate + placebo
Number of subjects: 53
Study: 28625164

Group type: EXPERIMENTAL
Intervention: Weekly teleconsultations with a specialist palliative care consultation team (SPCT) for 12 weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 74
Study: 27468140

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 69
Study: 24392964

Group type: EXPERIMENTAL
Intervention: Laser-assisted laterally positioned flap (LALPF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Laterally positioned flap (LPF)
Number of subjects: 32
Study: 22105893

Group type: COMPARATOR
Intervention: External Humidifier (EH)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Heat and Moisture Exchanger (HME)
Number of subjects: 53
Study: 20044678

Group type: EXPERIMENTAL
Intervention: Drains
Number of subjects: 78

Group type: COMPARATOR
Intervention: No drains
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study: 18753862

Group type: EXPERIMENTAL
Intervention: TPV/r 290/115 mg/m twice-daily
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: TPV/r 375/150 mg/m twice-daily
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: TPV/r (both doses)
Number of subjects: 115
Study: 15883444

Group type: EXPERIMENTAL
Intervention: Calcium-fortified milk (Ca milk)
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D-fortified milk (CaD milk)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Control
Number of subjects: 606
Study: 12767656

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Coronary Artery Bypass Graft (CABG)
Number of subjects: 389
Study: 10364784

Group type: EXPERIMENTAL
Intervention: Fructose-glucose-xylitol mixture (FGX)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 119
Study: 8678570

Group type: EXPERIMENTAL
Intervention: Itraconazole (7 mg/kg per day) for 3 weeks
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo for 3 weeks
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both groups (Itraconazole and Placebo)
Number of subjects: 140
Study: 8351043

Group type: EXPERIMENTAL
Intervention: Chewable antiplaque preparation containing chlorhexidine, fluoride, and xylitol
Number of subjects: 0
Study: 3528964

Group type: EXPERIMENTAL
Intervention: MP therapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: VCMP therapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Maintenance therapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Etoposide therapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Multidrug therapy (VBAMDex)
Number of subjects: 257
Study: 30056412

Group type: EXPERIMENTAL
Intervention: Hippotherapy simulator
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 27154574

Group type: EXPERIMENTAL
Intervention: Hypocapnic conditions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypercapnic conditions
Number of subjects: 40
Study: 23838692

Group type: EXPERIMENTAL
Intervention: Multi-family group therapy from MFEC
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (access to a range of interventions, but not multi-family therapy)
Number of subjects: 50
Study: 24133059

Group type: EXPERIMENTAL
Intervention: Garcinia cambogia extract (2.4 g, 800 mg 3×/day, 50% HCA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 22493101

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC) - three 5‐min cycles of upper limb ischaemia and reperfusion after anaesthesia induction.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control treatment (no specific details provided).
Number of subjects: 80
Study: 19283590

Group type: EXPERIMENTAL
Intervention: Moderate pressure massage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Light pressure massage
Number of subjects: 20
Study: 19070025

Group type: EXPERIMENTAL
Intervention: 300 mg ferrous sulfate 5 times/week
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo 5 times/week
Number of subjects: 94
Study: 16335907

Group type: EXPERIMENTAL
Intervention: Metformin (MET group, n = 48)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (ROSI group, n = 48)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 96
Study: 11995344

Group type: EXPERIMENTAL
Intervention: PGE1 infusion at a rate of 0.01 microgram.kg‐1.min‐1 during and after the operation (30‐40 hrs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no PGE1 infusion)
Number of subjects: 20
Study: 9701620

Group type: EXPERIMENTAL
Intervention: Dietary vitamin C intake (100 mg increment)
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Dietary vitamin C intake (100 mg increment) with higher calcium intake (>500 mg/day)
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Dietary vitamin C intake (100 mg increment) with lower calcium intake (<=500 mg/day)
Number of subjects: 775
Study: 8904263

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine premedication (0.14 mg/kg) with epidural morphine (4 mg immediately after operation and 3 mg ten hours later)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Epidural morphine (4 mg immediately after operation and 3 mg ten hours later)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intramuscular morphine premedication (0.14 mg/kg) with epidural saline (saline control)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Epidural saline (saline control)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine premedication (0.14 mg/kg)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 41
Study: 1898841

Group type: EXPERIMENTAL
Intervention: Clonidine (0.3‐0.4 mg orally)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Morphine (0.21 mg/kg intramuscularly)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clonidine plus Morphine (0.3‐0.4 mg orally and 0.21 mg/kg intramuscularly)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clonidine alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clonidine plus Morphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: All three drug groups
Number of subjects: 12
Study: 6682668

Group type: EXPERIMENTAL
Intervention: Ketotifen (2 mg daily for 6 months)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aminophylline (1050 mg daily for 6 months)
Number of subjects: 24
Study: 30411601

Group type: EXPERIMENTAL
Intervention: Classical relaxing music
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Self-selected relaxing music
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 32
Study: 30152603

Group type: EXPERIMENTAL
Intervention: STEPPS + treatment as usual
Number of subjects: 193

Group type: COMPARATOR
Intervention: treatment as usual alone
Number of subjects: 193
Study: 27492324

Group type: EXPERIMENTAL
Intervention: Selenium and/or vitamin E
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25489101

Group type: EXPERIMENTAL
Intervention: Fingolimod (0.5 mg per day orally for 3 consecutive days)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard management alone (Control)
Number of subjects: 22
Study: 21415283

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 99
Study: 19171951

Group type: EXPERIMENTAL
Intervention: Telemedicine case management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 17224709

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duloxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 0
Study: 14724397

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12242928

Group type: EXPERIMENTAL
Intervention: IVRA technique with the application of a simple forearm tourniquet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard IVRA technique
Number of subjects: 20
Study: 9657442

Group type: EXPERIMENTAL
Intervention: Nadroparin administered subcutaneously once daily at a dose of 180 anti-factor Xa IU.kg(‐1) for 6 to 10 days
Number of subjects: 36
Study: 7832822

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline 7 ml kg‐1
Number of subjects: 33

Group type: COMPARATOR
Intervention: 0.9% isotonic saline 7 ml kg‐1
Number of subjects: 33
Study: 2059591

Group type: EXPERIMENTAL
Intervention: Hydralazine (10 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Labetalol (100 mg)
Number of subjects: 30
Study: 6955678

Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride 250 mg qid for 10 days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Minocycline hydrochloride 100 mg bid for 10 days
Number of subjects: 59
Study: 30999056

Group type: EXPERIMENTAL
Intervention: injectable phloroglucinol
Number of subjects: 9

Group type: COMPARATOR
Intervention: stain remover (active control)
Number of subjects: 9

Group type: COMPARATOR
Intervention: water (placebo)
Number of subjects: 9
Study: 30094818

Group type: EXPERIMENTAL
Intervention: INTERACT program implementation
Number of subjects: 264

Group type: COMPARATOR
Intervention: Low or moderate INTERACT use
Number of subjects: 264
Study: 26806917

Group type: COMPARATOR
Intervention: Heart transplant (HT)
Number of subjects: 31
Study: 24801148

Group type: EXPERIMENTAL
Intervention: Multidose drug dispensing (MDD)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ordinary prescriptions (no MDD)
Number of subjects: 200
Study: 22956303

Group type: EXPERIMENTAL
Intervention: Brief Parent Training (BPT)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Regular services (comparison group)
Number of subjects: 216
Study: 19647623

Group type: EXPERIMENTAL
Intervention: Preoperative glutamine supplementation (0.3 g . kg(‐1) x d(‐1) for 5 days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no glutamine supplementation)
Number of subjects: 34
Study: 17721395

Group type: EXPERIMENTAL
Intervention: Raltegravir (100, 200, 400, and 600 mg twice daily)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Efavirenz (600 mg/d)
Number of subjects: 198
Study: 15746636

Group type: EXPERIMENTAL
Intervention: Redon drain (4 drains)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional drain (2 drains)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 12518847

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other treatments
Number of subjects: 0
Study: 9615306

Group type: COMPARATOR
Intervention: Salbutamol (1%) aerosol
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Furosemide aerosol (100 mg)
Number of subjects: 80
Study: 7856472

Group type: EXPERIMENTAL
Intervention: Nicardipine (1 mg/Kg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol (160 mg/day)
Number of subjects: 14
Study: 2610509

Group type: EXPERIMENTAL
Intervention: Cefixime alone (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefixime simultaneous with antacid (Maalox; 20 ml)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefixime 2 h before antacid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefixime 2 h after antacid
Number of subjects: 12
Study: 4552594

Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis
Number of subjects: 304

Group type: COMPARATOR
Intervention: Human diagnosis by the most senior member of the clinical team
Number of subjects: 304
Study: 31826360

Group type: EXPERIMENTAL
Intervention: Ribociclib plus fulvestrant
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 726
Study: 31323516

Group type: EXPERIMENTAL
Intervention: HAL (Hybrid Assistive Limb)
Number of subjects: 37

Group type: COMPARATOR
Intervention: CP (Conventional Physical therapy)
Number of subjects: 37
Study: 28606907

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula Therapy (HFNC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 120
Study: 25193390

Group type: EXPERIMENTAL
Intervention: Transenteral (TE) bowel preparation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Peroral (PO) bowel preparation
Number of subjects: 100
Study: 23470209

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid and carboxymethylcellulose (HA/CMC) instillation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lubricant instillation (control)
Number of subjects: 120
Study: 22093203

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg daily
Number of subjects: 88

Group type: COMPARATOR
Intervention: Famotidine 40 mg daily
Number of subjects: 88
Study: 19592108

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.15%
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dorzolamide hydrochloride 2%
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1%
Number of subjects: 120
Study: 16837920

Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (1.0 mM)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control calcium dialysate (1.62 mM)
Number of subjects: 51
Study: 12780410

Group type: EXPERIMENTAL
Intervention: Mean Deviation (MD)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Number of significant points
Number of subjects: 316
Study: 10951511

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation (350‐400 IU)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Vitamin K(1) supplementation (80 microg)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 9138625

Group type: EXPERIMENTAL
Intervention: Shy participants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Outgoing participants
Number of subjects: 30
Study: 8223351

Group type: EXPERIMENTAL
Intervention: Enoximone, 0.5 mg kg‐1 bolus followed by continuous infusion of 5 micrograms kg‐1 min‐1
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dobutamine, 7 micrograms kg‐1 min‐1
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dopamine, 5 micrograms kg‐1 min‐1
Number of subjects: 25
Study: 3780161

Group type: EXPERIMENTAL
Intervention: Piperacillin 4 g (sodium salt)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Azlocillin 4 g (sodium salt)
Number of subjects: 12
Study: 29853660

Group type: EXPERIMENTAL
Intervention: AMG 706 (motesanib) 125 mg per day orally combined with octreotide long acting-repeatable (LAR)
Number of subjects: 44
Study: 27193748

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) infusion (5 mg)
Number of subjects: 63
Study: 24525316

Group type: EXPERIMENTAL
Intervention: Vacc-4x
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 22014477

Group type: EXPERIMENTAL
Intervention: Aggressive early passive rehabilitation (manual therapy 2 times per day and unlimited self-passive stretching exercise) in group A (30 shoulders)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Limited early passive rehabilitation (limited continuous passive motion exercise and limited self-passive exercise) in group B (34 shoulders)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Aggressive early passive rehabilitation (group A)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Limited early passive rehabilitation (group B)
Number of subjects: 64
Study: 20399945

Group type: EXPERIMENTAL
Intervention: 0.02 mg ethinylestradiol/2 mg chlormadinone acetate (EE/CMA)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 0.02 mg ethinylestradiol/0.15 mg desogestrel (EE/DSG)
Number of subjects: 165

Group type: COMPARATOR
Intervention: 0.03 mg ethinylestradiol/0.15 mg levonorgestrel (EE/LNG)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 165
Study: 18029456

Group type: EXPERIMENTAL
Intervention: AA mixture
Number of subjects: 16

Group type: COMPARATOR
Intervention: ARG + LYS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Complete soy protein
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hydrolyzed soy protein
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Glucose concentrations
Number of subjects: 16
Study: 15963168

Group type: EXPERIMENTAL
Intervention: Ethnically tailored initial letters
Number of subjects: 4659

Group type: COMPARATOR
Intervention: General letters
Number of subjects: 4659

Group type: EXPERIMENTAL
Intervention: Spanish‐speaking Latinos
Number of subjects: 4659

Group type: EXPERIMENTAL
Intervention: Non‐Latino whites
Number of subjects: 4659

Group type: EXPERIMENTAL
Intervention: African Americans
Number of subjects: 4659

Group type: EXPERIMENTAL
Intervention: English‐speaking Latinos
Number of subjects: 4659